Colonics
About Me
Recent Posts
- Depression Doubles Risk Of Stroke In Middle-Aged Women
- Assessing The Efficacy Of Different Types Of Training Programs On Cognitive Performance In Elderly Patients
- Better Understanding Of Cells' Development Has Implications In Study Of Inflammatory Diseases
- How Much A Single Cell Breathes
- Insomnia Can Lead To Future Hospitalization And Increased Health Service Use
Menu
Calendar
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | 31 | ||
Friends
Links
Entry 1 of 2682
Last Page | Next Page
3/17/2010
-
Protalix BioTherapeutics commences clinical trial of human acetylcholinesterase for biodefense indications
|
Protalix BioTherapeutics, Inc. announced today that it has initiated a phase I clinical trial of PRX-105, the Company's plant cell denote pegylated recombinant human acetylcholinesterase product petitioner in growth for biodefense indications. The trial is designed to study the safety of PRX-105 by administering a bolus intravenous injection of PRX-105 in healthy volunteers. More: - Read More |
:: Send to a Friend! |
Share and enjoy
Report this!